Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07523555
What this trial is testing

Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLLRelapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia+4 more
Beijing Biotech 96
Testing effectiveness (Phase 2)Looking for participantsNCT02693535
What this trial is testing

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Who this might be right for
Lymphoma, Non-HodgkinMultiple MyelomaAdvanced Solid Tumors
American Society of Clinical Oncology 4,200
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Large-scale testing (Phase 3)Active Not RecruitingNCT00572169
What this trial is testing

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Who this might be right for
Multiple Myeloma
University of Arkansas 177
Not applicableStudy completedNCT00911105
What this trial is testing

Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone

Who this might be right for
Multiple Myeloma
iOMEDICO AG 101
Early research (Phase 1)Study completedNCT00458653
What this trial is testing

Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Beth Israel Deaconess Medical Center 45
Not applicableStudy completedNCT00569842
What this trial is testing

Investigation of the Cylex® ImmuKnow® Assay

Who this might be right for
LeukemiaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia+6 more
Indiana University 45
Not applicableStudy completedNCT01091883
What this trial is testing

Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma

Who this might be right for
Bone CancerBone MetastasesPain
InSightec 60
Not applicableLooking for participantsNCT07751783
What this trial is testing

Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations

Who this might be right for
CancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Lung Cancer (Non-Small Cell)+2 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 150
Early research (Phase 1)Looking for participantsNCT03110822
What this trial is testing

Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Who this might be right for
Multiple Myeloma
Oncotherapeutics 134
Large-scale testing (Phase 3)Ended earlyNCT00657553
What this trial is testing

Preemptive Strike With Bortezomib in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Early research (Phase 1)Ended earlyNCT00744354
What this trial is testing

Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
UNC Lineberger Comprehensive Cancer Center 32
Early research (Phase 1)Study completedNCT00089453
What this trial is testing

Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Large-scale testing (Phase 3)Looking for participantsNCT06561854
What this trial is testing

Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
Assistance Publique - Hôpitaux de Paris 318
Early research (Phase 1)UnknownNCT05412329
What this trial is testing

Study of Dual Targeted CD19/BCMA FASTCART GC012F in Relapsed/ Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 9
Testing effectiveness (Phase 2)Study completedNCT04436029
What this trial is testing

Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy

Who this might be right for
Multiple Myeloma
Cartesian Therapeutics 5
Not applicableLooking for participantsNCT06908629
What this trial is testing

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

Who this might be right for
CancerCancer SurvivorsGastrointestinal Cancers+2 more
Barbara Ann Karmanos Cancer Institute 120
Not applicableStudy completedNCT01697839
What this trial is testing

Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaPeripheral Neuropathy
Oncotherapeutics 110
Early research (Phase 1)UnknownNCT03618602
What this trial is testing

Safety, Pharmacokinetics and Efficacy Study of Bisthianostat in Refractory or Recurrent Multiple Myeloma Patients

Who this might be right for
Refractory Multiple MyelomaRecurrent Multiple Myeloma
Shanghai Theorion Pharmaceutical Co Ltd. 30
Not applicableStudy completedNCT02555839
What this trial is testing

Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice

Who this might be right for
Multiple Myeloma
Celgene 127
Next Page